Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Tencent Holdings has received regulatory approval to import Nvidia's advanced H200 AI chips, a significant move that enhances its competitive edge in cloud and AI services while navigating ongoing US technology restrictions.
Lawmakers are negotiating a short-term deal to fund the Department of Homeland Security, aiming to avoid a partial government shutdown this weekend. The talks occur against the backdrop of heightened political pressure following recent violence in Minneapolis and a shift in the administration's enforcement rhetoric.
In a new court filing, Hunter Biden's legal team moves to dismiss a contempt motion brought by the mother of his 7-year-old daughter, arguing his relationship with the child is legally irrelevant and denying violations of their 2023 support agreement.
Pakistani security forces conducted targeted military operations in the restive southwestern Balochistan province, resulting in the deaths of 41 militants. The raids signal an escalation in ongoing efforts to curb insurgent activities in the region.
The abduction of nearly 200 residents from Kurmin Wali has shattered community life, triggering a wave of departures as survivors lose faith in state protection and face an uncertain future.
Russian troops have taken control of three villages across Ukraine's Donetsk and Zaporizhzhia regions, according to a Defense Ministry statement reported by state media. The latest gains come amid intensified fighting along the front lines.
As data center demand surges, NextEra Energy emerges as a critical, and often overlooked, infrastructure player. Its partnerships with tech titans like Meta and Google highlight a strategic pivot in the energy sector.
A revised price target for Rithm Capital (NYSE: RITM) has prompted a fresh look at the mortgage REIT's prospects, with analysts weighing its strategic shifts against a complex macroeconomic backdrop.
Intuitive Machines (LUNR) is set to acquire Lanteris Space Systems in an $800 million deal, expanding its capabilities into vertically integrated space infrastructure. Concurrently, NASA has selected the company to provide critical tracking support for the upcoming Artemis II crewed lunar mission, signaling growing trust in its technical prowess.
After years of losses, London-listed Buccaneer Energy (LON:BUCE) is projected by analysts to turn its first profit in 2026, marking a potential turning point for the US-focused hydrocarbon explorer.
President Trump is expected to nominate former Fed governor Kevin Warsh as Jerome Powell's successor, a move markets interpret as a tilt toward more hawkish monetary policy and an end to months of uncertainty over the central bank's leadership.
Mitsubishi Corporation and U.S.-based Aethon Energy have announced a strategic global alliance aimed at co-developing projects across liquefied natural gas (LNG), carbon capture, geothermal energy, and digital infrastructure, marking a significant step in the Japanese conglomerate's lower-carbon expansion.
A fresh round of analyst price target adjustments for European asset manager Amundi (ENXTPA:AMUN) is prompting investors to recalibrate their expectations, placing renewed scrutiny on the firm's growth trajectory in a challenging macroeconomic climate.
Blue Owl Capital faces a wave of securities class actions alleging disclosure failures around liquidity and redemptions, casting a shadow over its robust alternative asset management platform. As legal pressures mount, the market weighs solid analyst backing against growing governance concerns, setting the stage for a pivotal earnings report.
United Rentals reported strong Q4 results, driven by data center and power sector demand, and issued 2026 guidance forecasting continued revenue growth. Management highlighted a robust project pipeline while navigating margin pressures.
In its Q4 2025 earnings call, SL Green Realty projected strong fundamentals for Manhattan's office market, citing robust leasing and AI-driven demand. Management reiterated ambitious 2026 financing and asset sale targets while reporting quarterly results that beat expectations.
H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.
Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.
